ImmunityBio
Commercializes ANKTIVA while developing cytokine, NK-cell, and vaccine immunotherapies for cancer.
$8.07
After-hours close+0.02 (+0.25%)
At close$8.05(−4.17%)
| Date | Estimate | Reported | Surprise |
|---|---|---|---|
| Nov 2026 | −$0.08 | — | — |
| Aug 2026 | −$0.08 | −$0.22 | −175.0% |
| May 2026 | −$0.08 | −$0.09 | −12.5% |
| Feb 2026 | −$0.08 | −$0.06 | +25.0% |
| Nov 2025 | −$0.10 | −$0.07 | +30.0% |
The latest year is open to everyone — the 41 quarters behind it read with an account. Sign in | |||
| Aug 2025 | |||
| May 2025 | |||
| Mar 2025 | |||
| Nov 2024 | |||
| Aug 2024 | |||
| May 2024 | |||
| Mar 2024 | |||
| Nov 2023 | |||
| Aug 2023 | |||
| May 2023 | |||
| Mar 2023 | |||
| Nov 2022 | |||
| Aug 2022 | |||
| May 2022 | |||
| Mar 2022 | |||
| Nov 2021 | |||
| Aug 2021 | |||
| May 2021 | |||
| Mar 2021 | |||
| Nov 2020 | |||
| Aug 2020 | |||
| May 2020 | |||
| Mar 2020 | |||
| Nov 2019 | |||
| Aug 2019 | |||
| May 2019 | |||
| Mar 2019 | |||
| Nov 2018 | |||
| Aug 2018 | |||
| May 2018 | |||
| Mar 2018 | |||
| Nov 2017 | |||
| Aug 2017 | |||
| May 2017 | |||
| Mar 2017 | |||
| Nov 2016 | |||
| Aug 2016 | |||
| May 2016 | |||
| Mar 2016 | |||
| Nov 2015 | |||
| Sep 2015 | |||
| Report date | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise |
|---|---|---|---|---|---|---|
| Nov 3, 2026 | −$0.08 | — | — | $59.2M | — | — |
| Aug 4, 2026 | −$0.08 | −$0.22 | −175.0% | $49.7M | $51.2M | +3.1% |
| May 7, 2026 | −$0.08 | −$0.09 | −12.5% | $43.1M | $44.2M | +2.6% |
| Feb 23, 2026 | −$0.08 | −$0.06 | +25.0% | $38.4M | $38.3M | −0.2% |
| Nov 4, 2025 | −$0.10 | −$0.07 | +30.0% | $37.8M | $32.1M | −15.1% |
The latest year is open to everyone — the 41 quarters behind it read with an account. Sign in | ||||||
| Aug 5, 2025 | ||||||
| May 12, 2025 | ||||||
| Mar 3, 2025 | ||||||
| Nov 12, 2024 | ||||||
| Aug 12, 2024 | ||||||
| May 9, 2024 | ||||||
| Mar 19, 2024 | ||||||
| Nov 8, 2023 | ||||||
| Aug 8, 2023 | ||||||
| May 11, 2023 | ||||||
| Mar 1, 2023 | ||||||
| Nov 9, 2022 | ||||||
| Aug 8, 2022 | ||||||
| May 10, 2022 | ||||||
| Mar 2, 2022 | ||||||
| Nov 12, 2021 | ||||||
| Aug 12, 2021 | ||||||
| May 14, 2021 | ||||||
| Mar 4, 2021 | ||||||
| Nov 9, 2020 | ||||||
| Aug 7, 2020 | ||||||
| May 11, 2020 | ||||||
| Mar 25, 2020 | ||||||
| Nov 5, 2019 | ||||||
| Aug 6, 2019 | ||||||
| May 8, 2019 | ||||||
| Mar 13, 2019 | ||||||
| Nov 7, 2018 | ||||||
| Aug 6, 2018 | ||||||
| May 7, 2018 | ||||||
| Mar 12, 2018 | ||||||
| Nov 7, 2017 | ||||||
| Aug 7, 2017 | ||||||
| May 8, 2017 | ||||||
| Mar 15, 2017 | ||||||
| Nov 10, 2016 | ||||||
| Aug 15, 2016 | ||||||
| May 16, 2016 | ||||||
| Mar 30, 2016 | ||||||
| Nov 12, 2015 | ||||||
| Sep 10, 2015 | ||||||